Samuel Funt, MD
Disclosures: Ownership Interest-Kite Pharma,Ownership Interest-Urogen Pharma,Contracted Research-Genentech, Inc.,Contracted Research-AstraZeneca,Ownership Interest-Allogene
No Bio Available.